4-fluoro-N-[[2-[(2-propan-2-ylpyrazol-3-yl)methyl]-2,3-dihydroimidazo[1,2-b]pyridazin-7-yl]methyl]pentanamide
C19H27FN6O — CID 157031288
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-fluoro-N-[[2-[(2-propan-2-ylpyrazol-3-yl)methyl]-2,3-dihydroimidazo[1,2-b]pyridazin-7-yl]methyl]pentanamide
4-fluoro-N-[[2-[(2-propan-2-ylpyrazol-3-yl)methyl]-2,3-dihydroimidazo[1,2-b]pyridazin-7-yl]methyl]pentanamide (PubChem CID 157031288) has the molecular formula C19H27FN6O and a molecular weight of 374.46 g/mol. Its IUPAC name is 4-fluoro-N-[[2-[(2-propan-2-ylpyrazol-3-yl)methyl]-2,3-dihydroimidazo[1,2-b]pyridazin-7-yl]methyl]pentanamide.
Molecular Properties
| Compound Name | 4-fluoro-N-[[2-[(2-propan-2-ylpyrazol-3-yl)methyl]-2,3-dihydroimidazo[1,2-b]pyridazin-7-yl]methyl]pentanamide |
|---|---|
| PubChem CID | 157031288 |
| Molecular Formula | C19H27FN6O |
| Molecular Weight | 374.46 g/mol |
| Exact Mass | 374.22 |
| IUPAC Name | 4-fluoro-N-[[2-[(2-propan-2-ylpyrazol-3-yl)methyl]-2,3-dihydroimidazo[1,2-b]pyridazin-7-yl]methyl]pentanamide |
| SMILES | CC(F)CCC(=O)NCC1=CC2=NC(Cc3ccnn3C(C)C)CN2N=C1 |
| InChI | InChI=1S/C19H27FN6O/c1-13(2)26-17(6-7-22-26)9-16-12-25-18(24-16)8-15(11-23-25)10-21-19(27)5-4-14(3)20/h6-8,11,13-14,16H,4-5,9-10,12H2,1-3H3,(H,21,27) |
| InChIKey | MXXRMMSVLCCCBR-UHFFFAOYSA-N |
| XLogP | 2.27 |
| TPSA | 74.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 374.46 |
| LogP ≤ 5 | 2.27 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157031288 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.